France has ordered 50,000 doses of Merck & Co’s experimental COVID-19 antiviral drug for adults, the country’s health minister Olivier Veran told a hearing at the French Senate on Tuesday.
“France positioned itself very early in pre-ordering. France ordered 50,000 doses of the drug,” Veran told lawmakers about molnupiravir, which is Merck & Co’s experimental antiviral pills
to treat COVID-19 ailments.
Read the latest updates in our dedicated coronavirus section.
Governments around the world are preparing to ensure they can cope any pick-up in the COVID virus as the winter season approaches in the northern hemisphere.
For the latest headlines, follow our Google News channel online or via the app.
Merck & Co said on Monday that the European Union’s drug regulator had initiated a real-time review of its experimental COVID antiviral drug for adults.
While vaccines are the main weapons against COVID-19, Merck’s experimental pill molnupiravir could be a game-changer after studies showed it could halve the chances of dying or being hospitalized for those most at risk of contracting severe illness.
Read more:
EU regulator starts real-time review of US drugmaker Merck’s COVID-19 pill
Expo 2020 Dubai: WHO chief urges more COVID-19 vaccine help for poor nations
Also Read
-
Saudi Arabia came out ahead of COVID pandemic, proved its resilience: Al-Falih at FII
-
London’s Heathrow says despite pick-up, full travel recovery at least five years away
-
China locks down Lanzhou, city of 4 million, over COVID-19
-
Saudi Arabia’s tourism minister calls for a unified travel protocol post-COVID
-
Number of COVID-19 infections in Spain hits five million
-
Morocco’s health minister defends mandatory COVID-19 vaccine pass
-
Expo 2020 Dubai: WHO chief urges more COVID-19 vaccine help for poor nations
-
Hong Kong to tighten COVID-19 rules, seeks to open to China